Thick meconium strongly associated with increased NICU admission, prolonged hospitalization: Study
Meconium-stained amniotic fluid (MSAF) is a common occurrence in obstetric practice and is linked to various neonatal complications. The passage of meconium into the amniotic fluid during pregnancy or labor can lead to significant risks, such as perinatal asphyxia, meconium aspiration syndrome (MAS), and other morbidities that affect newborn health. MSAF is classified into two types: nonsignificant meconium-stained liquor (MSL) and significant MSL. Non-significant MSL is characterized by thin, yellowish or greenish fluid containing non-particulate meconium, while significant MSL involves thick, dark green or black fluid with visible lumps or clumps of meconium.
The meconium in the amniotic fluid consists of a mixture of fetal waste products, including desquamated cells from the intestines and skin, lanugo hair, mucin, fatty material from the vernix caseosa, and other gastrointestinal secretions. While the exact causes of meconium passage are not fully understood, certain obstetric conditions are known to increase the likelihood of MSAF. These include prolonged labor, post-term pregnancies, oligohydramnios, intrauterine growth restriction, hypertensive disorders, and low birth weight.
The presence of meconium in the amniotic fluid is a risk factor for several neonatal complications. These can include the need for immediate resuscitation at birth, respiratory distress, lower Apgar scores, admission to neonatal intensive care units, and increased risk of neonatal infections. One of the most serious consequences of MSAF is meconium aspiration syndrome (MAS), which affects 5-10% of neonates with MSAF and is a leading cause of neonatal morbidity and mortality. In addition to short-term risks, there are concerns about long-term neurological outcomes, including developmental delays and cerebral palsy.
This study aimed to assess the short-term neonatal outcomes associated with meconium-stained liquor, with a particular focus on comparing the effects of thick versus thin meconium-stained fluid on newborn health. The goal is to better understand how the severity of meconium staining influences neonatal outcomes and to inform clinical management strategies for pregnancies complicated by MSAF.
This prospective study was conducted at a tertiary care teaching hospital. The research focused on infants born to mothers with meconium-stained amniotic fluid, classifying the newborns into two groups based on the meconium's thickness observed at birth: thin and thick.
The study included 174 neonates born to mothers with MSAF, with a mean gestational age of 37.6 ± 2.1 weeks. Among the participants, 51.4% had vaginal deliveries. Of the total infants, 73% (127 neonates) had thick meconium, while 27% (47 neonates) had thin meconium. A significant portion (80%) of the infants with MSAF required admission to the NICU, while 20% were able to stay with their mothers. Infants with thick meconium had notably longer stays in the NICU and were more likely to require invasive ventilation compared to those with thin meconium. Of the 127 neonates with thick meconium, 93% were discharged, with a 6% mortality rate. In comparison, 89% of the 47 infants with thin meconium survived, with 11% experiencing mortality.
This study confirmed that thick meconium is associated with a higher need for NICU admission, a longer duration of hospital stay, and an increased requirement for ventilation (both invasive and non-invasive) compared to thin meconium. These findings highlight the importance of early identification and appropriate neonatal management for infants born with meconium-stained amniotic fluid, particularly in cases with thick meconium, in order to reduce the risk of complications and improve outcomes.
Source: Mundlod et al. / Indian Journal of Obstetrics and Gynecology Research 2026;13(1):96–101
